Newsletter | December 22, 2025

12.22.25 -- Deploying Viruses To Counter Antibiotics Resistance

FEATURED EDITORIAL

Deploying Viruses To Counter Antibiotics Resistance

Biologics platform delivery developer Paldara Pharmaceuticals talks about infection-combatting alternatives using hydrogel-based systems to deliver bacteriophage viral therapeutics directly to infection sites.

Is Oncology Precision Medicine Coming of Age?

Developers are releasing new data suggesting that their targeted therapy candidates may finally address some of oncology’s toughest challenges.

INDUSTRY INSIGHTS

De-Risking FDA Abbreviated New Drug Application (ANDA) Submissions

The autoinjector platform for tirzepatide supports FDA ANDA submissions with proven usability, low error rates, and a design validated to match the reference listed device.

The Convergence Of MedTech And Pharma Product Development

MedTech accelerates innovation through acquisition and integration while pharma sustains research depth by distributing risk and cost. These distinct paths are reshaping product development.

Micronization For Desired Particle Size And Yield

In this webinar, experts examine how the right combination of advanced technology and specialized expertise can leverage micronization to address the challenges often faced by small molecule drugs.

Subcutaneous mAb Delivery Using Nanoformed Particles

A highly concentrated non-aqueous suspension of an IgG1 was developed using a patented platform. Review how the particle size of the mAb impacts the overall behavior of the drug product.

Accelerating Therapy Development For Rare Disease Targets

This comprehensive exploration aims to shed light on the critical aspects of expediting curative therapies, with a focus on the strategic role that CDMOs can play in this transformative journey.

Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs

Ready-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.

SOLUTIONS

Oral Solid Dosage Technology

Navigating Regulatory Complexity For Combination Products